Literature DB >> 18723129

Altered B cell receptor signaling in human systemic lupus erythematosus.

Scott A Jenks1, Iñaki Sanz.   

Abstract

Regulation of B cell receptor signaling is essential for the development of specific immunity while retaining tolerance to self. Systemic lupus erythematosus (SLE) is characterized by a loss of B cell tolerance and the production of anti-self antibodies. Accompanying this break down in tolerance are alterations in B cell receptor signal transduction including elevated induced calcium responses and increased protein phosphorylation. Specific pathways that negatively regulate B cell signaling have been shown to be impaired in some SLE patients. These patients have reduced levels of the kinase Lyn in lipid raft microdomains and this reduction is inversely correlated with increased CD45 in lipid rafts. Function and expression of the inhibitory immunoglobulin receptor FcgammaRIIB is also reduced in Lupus IgM- CD27+ memory cells. Because the relative contribution of different memory and transitional B cell subsets can be abnormal in SLE patients, we believe studies targeted to well defined B cell subsets will be necessary to further our understanding of signaling abnormalities in SLE. Intracellular flow cytometric analysis of signaling is a useful approach to accomplish this goal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723129      PMCID: PMC2693706          DOI: 10.1016/j.autrev.2008.07.047

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  40 in total

1.  FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling.

Authors:  Hajime Kono; Chieko Kyogoku; Takeshi Suzuki; Naoyuki Tsuchiya; Hiroaki Honda; Kazuhiko Yamamoto; Katsushi Tokunaga; Zen-Ichiro Honda
Journal:  Hum Mol Genet       Date:  2005-08-22       Impact factor: 6.150

2.  Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus.

Authors:  Fabian Flores-Borja; Panagiotis S Kabouridis; Elizabeth C Jury; David A Isenberg; Rizgar A Mageed
Journal:  Arthritis Rheum       Date:  2007-01

3.  Defective FcgammaRIIb1 signaling contributes to enhanced calcium response in B cells from patients with systemic lupus erythematosus.

Authors:  E J Enyedy; J P Mitchell; M P Nambiar; G C Tsokos
Journal:  Clin Immunol       Date:  2001-11       Impact factor: 3.969

Review 4.  Cellular and genetic mechanisms of self tolerance and autoimmunity.

Authors:  Christopher C Goodnow; Jonathon Sprent; Barbara Fazekas de St Groth; Carola G Vinuesa
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

5.  Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.

Authors:  S Bolland; J V Ravetch
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

6.  Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus.

Authors:  Marissa C Blank; Radu N Stefanescu; Emi Masuda; Francesc Marti; Philip D King; Patricia B Redecha; Robert J Wurzburger; Margaret G E Peterson; Shizuko Tanaka; Luminita Pricop
Journal:  Hum Genet       Date:  2005-05-14       Impact factor: 4.132

7.  B-cell kinase lyn deficiency in patients with systemic lupus erythematosus.

Authors:  S N Liossis; E E Solomou; M A Dimopoulos; P Panayiotidis; M M Mavrikakis; P P Sfikakis
Journal:  J Investig Med       Date:  2001-03       Impact factor: 2.895

8.  Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.

Authors:  Chieko Kyogoku; Hilde M Dijstelbloem; Naoyuki Tsuchiya; Yoko Hatta; Hitoshi Kato; Akihiro Yamaguchi; Toru Fukazawa; Marc D Jansen; Hiroshi Hashimoto; Jan G J van de Winkel; Cees G M Kallenberg; Katsushi Tokunaga
Journal:  Arthritis Rheum       Date:  2002-05

Review 9.  How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype.

Authors:  José C Crispín; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  Trends Immunol       Date:  2008-02-04       Impact factor: 16.687

Review 10.  Dysfunctional B cells in systemic lupus erythematosus.

Authors:  Yves Renaudineau; Jacques-Olivier Pers; Boutahar Bendaoud; Christophe Jamin; Pierre Youinou
Journal:  Autoimmun Rev       Date:  2004-11       Impact factor: 9.754

View more
  30 in total

1.  Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.

Authors:  Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

2.  Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.

Authors:  Chuancang Jiang; Ming-Lang Zhao; Richard M Scearce; Marilyn Diaz
Journal:  Arthritis Rheum       Date:  2011-04

3.  Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase.

Authors:  Julien Mahé; Emilie Patras de Campaigno; Anne-Laure Chené; Jean-Louis Montastruc; Fabien Despas; Pascale Jolliet
Journal:  Br J Clin Pharmacol       Date:  2018-08-05       Impact factor: 4.335

Review 4.  Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

Authors:  Patrice Hemon; Yves Renaudineau; Marjolaine Debant; Nelig Le Goux; Sreya Mukherjee; Wesley Brooks; Olivier Mignen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

Review 5.  Rationale for B cell targeting in SLE.

Authors:  Iñaki Sanz
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

6.  PKK deficiency in B cells prevents lupus development in Sle lupus mice.

Authors:  D Oleksyn; J Zhao; A Vosoughi; J C Zhao; R Misra; A P Pentland; D Ryan; J Anolik; C Ritchlin; J Looney; A P Anandarajah; G Schwartz; L M Calvi; M Georger; C Mohan; I Sanz; L Chen
Journal:  Immunol Lett       Date:  2017-03-06       Impact factor: 3.685

7.  Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus.

Authors:  Deshan Ren; Fei Liu; Guanjun Dong; Ming You; Jianjian Ji; Yahong Huang; Yayi Hou; Hongye Fan
Journal:  Cell Mol Immunol       Date:  2015-07-06       Impact factor: 11.530

8.  Cutting Edge: Deletion of Ezrin in B Cells of Lyn-Deficient Mice Downregulates Lupus Pathology.

Authors:  Debasis Pore; Emily Huang; Dina Dejanovic; Neetha Parameswaran; Michael B Cheung; Neetu Gupta
Journal:  J Immunol       Date:  2018-07-18       Impact factor: 5.422

Review 9.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

10.  Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision.

Authors:  Anne Doster; Saskia Ziegler; Sandra Foermer; Ralf Joachim Rieker; Klaus Heeg; Isabelle Bekeredjian-Ding
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.